DK1144421T3 - Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser - Google Patents

Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser

Info

Publication number
DK1144421T3
DK1144421T3 DK00900598T DK00900598T DK1144421T3 DK 1144421 T3 DK1144421 T3 DK 1144421T3 DK 00900598 T DK00900598 T DK 00900598T DK 00900598 T DK00900598 T DK 00900598T DK 1144421 T3 DK1144421 T3 DK 1144421T3
Authority
DK
Denmark
Prior art keywords
amino acid
natural
lateral chain
inhibitors
pseudopeptides
Prior art date
Application number
DK00900598T
Other languages
Danish (da)
English (en)
Inventor
Vincent Dive
Philippe Cuniasse
Marie-Christine Rio
Athanasios Yotakis
Fabrice Beau
Stamania Vassiliou
Paul Di Basset
Original Assignee
Commissariat Energie Atomique
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Inst Nat Sante Rech Med, Centre Nat Rech Scient filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of DK1144421T3 publication Critical patent/DK1144421T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
DK00900598T 1999-01-19 2000-01-18 Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser DK1144421T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900509A FR2788525B1 (fr) 1999-01-19 1999-01-19 Pseudo-peptides phosphiniques, utilisables comme inhibiteurs des metalloproteases a zinc matricielles

Publications (1)

Publication Number Publication Date
DK1144421T3 true DK1144421T3 (da) 2004-02-16

Family

ID=9540989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900598T DK1144421T3 (da) 1999-01-19 2000-01-18 Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser

Country Status (10)

Country Link
US (1) US6630501B1 (ja)
EP (1) EP1144421B1 (ja)
JP (1) JP2003517450A (ja)
AT (1) ATE251630T1 (ja)
CA (1) CA2360787A1 (ja)
DE (1) DE60005788T2 (ja)
DK (1) DK1144421T3 (ja)
ES (1) ES2208260T3 (ja)
FR (1) FR2788525B1 (ja)
WO (1) WO2000043404A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922577D0 (en) * 1999-09-23 1999-11-24 Center For Clinical & Basic Re Substituted phosphinate based peptide derivatives
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
DE602004011255T2 (de) * 2003-11-11 2009-01-08 F. Hoffmann-La Roche Ag Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
WO2007062376A2 (en) * 2005-11-21 2007-05-31 Florida Atlantic University Selective inhibition of matrix metalloproteinases
FR2996003B1 (fr) 2012-09-25 2014-10-17 Commissariat Energie Atomique Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active
TWI743023B (zh) * 2014-05-21 2021-10-21 日商Ｋｍ生物醫藥股份有限公司 基質金屬蛋白酶 7(mmp-7)聚集體之單體化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676059B1 (fr) 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
WO1993014112A1 (en) * 1992-01-15 1993-07-22 Merck & Co., Inc. Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
FR2689764B1 (fr) 1992-04-10 1995-05-12 Commissariat Energie Atomique Utilisation de dérivés de peptides pour la fabrication de médicaments inhibiteurs des endopeptidases 24.15 et 24.16.
FR2730235A1 (fr) 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15
IL127567A0 (en) * 1996-07-18 1999-10-28 Pfizer Phosphinate based inhibitors of matrix metalloproteases

Also Published As

Publication number Publication date
EP1144421A1 (fr) 2001-10-17
JP2003517450A (ja) 2003-05-27
WO2000043404A1 (fr) 2000-07-27
CA2360787A1 (fr) 2000-07-27
FR2788525B1 (fr) 2002-11-29
US6630501B1 (en) 2003-10-07
FR2788525A1 (fr) 2000-07-21
ES2208260T3 (es) 2004-06-16
ATE251630T1 (de) 2003-10-15
EP1144421B1 (fr) 2003-10-08
DE60005788T2 (de) 2004-08-19
DE60005788D1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
BR0210504A (pt) Derivados de naftil-indol substituidos, atuantes como inibidores do inibidor tipo 1 (pai-1) do ativador de plasminogênio
HUP0100901A2 (hu) 20S Ptoteaszóma alfa-ketoamidin inhibitor hatású peptidszármazékok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
DE60301345D1 (de) Stabilisierte askorbinsäurederivate
EA200100600A3 (ru) Новые соединения дифенилмочевины, способ их получения и содержащие их фармацевтические композиции
ATE383160T1 (de) Phosphinsäurederivate, inhibitoren von beta- sekretase zur behandlung von alzheimer-krankheit
PT1250340E (pt) Metodos e compostos para inibicao de mrp1
ATE19251T1 (de) Hemmer der kollagenase der saeugetiere.
DK1144421T3 (da) Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser
DE69712758T2 (de) Fungizide zusammensetzungen
AU4663301A (en) Method for preparing (2S,3R,4S)-4-hydroxyisoleucine and analogues thereof
DE60215917D1 (de) Tripepide und tripepdid-derivte zur behandlung von neurodegenerativen erkrankungen
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
AU2003220441A8 (en) Dipeptidic growth hormone secretagogues
ATE342250T1 (de) Verfahren zur herstellung von (aminomethyl)trifluoromethylcarbinol-derivaten
AU2009292741A8 (en) Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
FR2834989B1 (fr) Derives de pseudo-peptides phosphiniques inhibant selectivement le site actif c-terminal de l'enzyme de conversion de l'angiotensine i(ace)
DE602004026110D1 (de) Verfahren zur inhibierung der verfärbung von methylenbisanilinverbindungen
BR0316368A (pt) Análogos de ácido fosfìnico de glutamato
BRPI0413743A (pt) inibidores de catepsina s
Green et al. Substrate related O, O-dialkyldipeptidyly ψ carboxybenzylphosphonates, a new type of thrombin inhibitor
WO2004065411A3 (en) Peptides
TW200510330A (en) Enhancement of bone growth and inhibition of bone resorption